NICE-话题@MedSci

#NICE#

226篇内容 | 5180人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1289020, encodeId=16a312890201b, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=不错的180度大转弯——NICE支持Roche的Tecentriq用于肺癌的治疗, objectType=article, longId=134741, objectId=0b12134e4108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b12134e4108, replyNumber=0, likeNumber=57, createdTime=2018-04-11, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b12134e4108, moduleTitle=不错的180度大转弯——NICE支持Roche的Tecentriq用于肺癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b12134e4108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289019, encodeId=806e12890192f, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=Ipsen的Cometriq获NICE资助, objectType=article, longId=133740, objectId=6ab3133e4093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ab3133e4093, replyNumber=0, likeNumber=67, createdTime=2018-03-30, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ab3133e4093, moduleTitle=Ipsen的Cometriq获NICE资助, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ab3133e4093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289018, encodeId=01a812890180d, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE拒绝资助cenegermin,一种罕见的眼疾药物, objectType=article, longId=133027, objectId=0e0913302ea0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e0913302ea0, replyNumber=0, likeNumber=47, createdTime=2018-03-22, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e0913302ea0, moduleTitle=NICE拒绝资助cenegermin,一种罕见的眼疾药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e0913302ea0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289017, encodeId=1986128901ebc, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE支持Keytruda用于膀胱癌的治疗, objectType=article, longId=132694, objectId=f12f1326941e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f12f1326941e, replyNumber=0, likeNumber=59, createdTime=2018-03-18, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f12f1326941e, moduleTitle=NICE支持Keytruda用于膀胱癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f12f1326941e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289016, encodeId=978c128901664, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=拜耳的Stivarga未被NICE纳入肝癌的治疗, objectType=article, longId=129524, objectId=a7e512952456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7e512952456, replyNumber=0, likeNumber=50, createdTime=2018-02-11, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7e512952456, moduleTitle=拜耳的Stivarga未被NICE纳入肝癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7e512952456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289015, encodeId=12a012890157f, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE/PHE反对使用抗生素治疗喉咙痛, objectType=article, longId=127905, objectId=270612e90591, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=270612e90591, replyNumber=0, likeNumber=60, createdTime=2018-01-28, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=270612e90591, moduleTitle=NICE/PHE反对使用抗生素治疗喉咙痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=270612e90591)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289014, encodeId=9b6b1289014ef, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=拜耳的Stivarga被纳入NICE用于治疗胃肠道间质肿瘤, objectType=article, longId=120880, objectId=71d4120880c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71d4120880c2, replyNumber=0, likeNumber=68, createdTime=2017-11-22, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71d4120880c2, moduleTitle=拜耳的Stivarga被纳入NICE用于治疗胃肠道间质肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71d4120880c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289013, encodeId=e7d412890135c, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）, objectType=article, longId=111847, objectId=deec11184ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deec11184ecd, replyNumber=0, likeNumber=23, createdTime=2017-09-05, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deec11184ecd, moduleTitle=2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=deec11184ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289012, encodeId=2ff612890125e, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=NICE评准更新：所有慢性肾病患者都应吃他汀, objectType=article, longId=107961, objectId=393910e961ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393910e961ce, replyNumber=0, likeNumber=88, createdTime=2017-08-09, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393910e961ce, moduleTitle=NICE评准更新：所有慢性肾病患者都应吃他汀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393910e961ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289011, encodeId=cdf21289011dc, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=Shire胰腺癌药物Onivyde惨遭英国NICE拒绝！, objectType=article, longId=94073, objectId=0c71940e386, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c71940e386, replyNumber=0, likeNumber=62, createdTime=2017-03-31, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c71940e386, moduleTitle=Shire胰腺癌药物Onivyde惨遭英国NICE拒绝！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c71940e386)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289009, encodeId=6cec128900936, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=精品指南：2016NICE指南：结核病（NG.33）内容要点概括（内附上海肺科医院专家视频）, objectType=article, longId=93074, objectId=0083930e446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0083930e446, replyNumber=0, likeNumber=53, createdTime=2017-03-25, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0083930e446, moduleTitle=精品指南：2016NICE指南：结核病（NG.33）内容要点概括（内附上海肺科医院专家视频）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0083930e446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289010, encodeId=f8d7128901001, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=【精品指南】2016NICE指南：结核病（NG.33）内容要点概括（内附上海肺科医院专家视频）, objectType=article, longId=93075, objectId=c160930e570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c160930e570, replyNumber=0, likeNumber=53, createdTime=2017-03-25, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c160930e570, moduleTitle=【精品指南】2016NICE指南：结核病（NG.33）内容要点概括（内附上海肺科医院专家视频）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c160930e570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289008, encodeId=6168128900866, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=喜讯！诺华重磅抗炎药Cosentyx获英国NICE批准治疗银屑病关节炎（PsA）, objectType=article, longId=86942, objectId=2a528694223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a528694223, replyNumber=0, likeNumber=0, createdTime=2017-01-09, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a528694223, moduleTitle=喜讯！诺华重磅抗炎药Cosentyx获英国NICE批准治疗银屑病关节炎（PsA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a528694223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289007, encodeId=494a128900eee, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=喜讯！罗氏乳腺癌新药Perjeta获英国NICE批准用于HER2阳性乳腺癌新辅助治疗, objectType=article, longId=86807, objectId=8ea08680e9d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ea08680e9d, replyNumber=0, likeNumber=69, createdTime=2017-01-07, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ea08680e9d, moduleTitle=喜讯！罗氏乳腺癌新药Perjeta获英国NICE批准用于HER2阳性乳腺癌新辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ea08680e9d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289006, encodeId=16291289006ec, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=罕见病新药递送！英国NICE批准Amicus公司法布里病新药Galafold, objectType=article, longId=86732, objectId=94fe86e32bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94fe86e32bc, replyNumber=0, likeNumber=51, createdTime=2017-01-07, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94fe86e32bc, moduleTitle=罕见病新药递送！英国NICE批准Amicus公司法布里病新药Galafold, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94fe86e32bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289005, encodeId=7844128900550, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2016 NICE指南：婴幼儿，儿童和年轻人临终关怀（NG.61）, objectType=article, longId=83952, objectId=052c8395250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052c8395250, replyNumber=0, likeNumber=0, createdTime=2016-12-11, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052c8395250, moduleTitle=2016 NICE指南：婴幼儿，儿童和年轻人临终关怀（NG.61）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=052c8395250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289004, encodeId=941b1289004f8, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015 NICE指南：慢性肾病患者贫血的管理（NG8）, objectType=article, longId=83951, objectId=6caf83951ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6caf83951ab, replyNumber=0, likeNumber=21, createdTime=2016-12-11, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6caf83951ab, moduleTitle=2015 NICE指南：慢性肾病患者贫血的管理（NG8）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6caf83951ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289003, encodeId=d7121289003cb, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015 NICE技术评估指南：阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防（TA341）, objectType=article, longId=83836, objectId=83ca838360f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83ca838360f, replyNumber=0, likeNumber=22, createdTime=2016-12-10, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83ca838360f, moduleTitle=2015 NICE技术评估指南：阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防（TA341）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83ca838360f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289002, encodeId=011912890028d, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015 NICE指南：降低成人住院患者静脉血栓栓塞风险（CG92）, objectType=article, longId=83828, objectId=21a2838283a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21a2838283a, replyNumber=0, likeNumber=20, createdTime=2016-12-10, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21a2838283a, moduleTitle=2015 NICE指南：降低成人住院患者静脉血栓栓塞风险（CG92）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21a2838283a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1289001, encodeId=5dc81289001a6, content=<a href='/topic/show?id=077112e9237' target=_blank style='color:#2F92EE;'>#NICE#</a>, objectTitle=2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）, objectType=article, longId=83778, objectId=4dcc83e787c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4dcc83e787c, replyNumber=0, likeNumber=22, createdTime=2016-12-09, rootId=0, userName=fusion, userId=743b215, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4dcc83e787c, moduleTitle=2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dcc83e787c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NICE

2020-05-29

fusion (审核中...)

前往app查看评论内容

#NICE#

不错的180度大转弯——NICE支持Roche的Tecentriq用于肺癌的治疗

2018-04-11

fusion (审核中...)

前往app查看评论内容

#NICE#

Ipsen的Cometriq获NICE资助

2018-03-30

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE拒绝资助cenegermin,一种罕见的眼疾药物

2018-03-22

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE支持Keytruda用于膀胱癌的治疗

2018-03-18

fusion (审核中...)

前往app查看评论内容

#NICE#

拜耳的Stivarga未被NICE纳入肝癌的治疗

2018-02-11

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE/PHE反对使用抗生素治疗喉咙痛

2018-01-28

fusion (审核中...)

前往app查看评论内容

#NICE#

拜耳的Stivarga被纳入NICE用于治疗胃肠道间质肿瘤

2017-11-22

fusion (审核中...)

前往app查看评论内容

#NICE#

2017 NICE诊断指南：多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理（DG.29）

2017-09-05

fusion (审核中...)

前往app查看评论内容

#NICE#

NICE评准更新：所有慢性肾病患者都应吃他汀

2017-08-09

fusion (审核中...)

前往app查看评论内容

#NICE#

Shire胰腺癌药物Onivyde惨遭英国NICE拒绝！

2017-03-31

fusion (审核中...)

前往app查看评论内容

#NICE#

精品指南：2016NICE指南：结核病（NG.33）内容要点概括（内附上海肺科医院专家视频）

2017-03-25

fusion (审核中...)

前往app查看评论内容

#NICE#

【精品指南】2016NICE指南：结核病（NG.33）内容要点概括（内附上海肺科医院专家视频）

2017-03-25

fusion (审核中...)

前往app查看评论内容

#NICE#

喜讯！诺华重磅抗炎药Cosentyx获英国NICE批准治疗银屑病关节炎（PsA）

2017-01-09

fusion (审核中...)

前往app查看评论内容

#NICE#

喜讯！罗氏乳腺癌新药Perjeta获英国NICE批准用于HER2阳性乳腺癌新辅助治疗

2017-01-07

fusion (审核中...)

前往app查看评论内容

#NICE#

罕见病新药递送！英国NICE批准Amicus公司法布里病新药Galafold

2017-01-07

fusion (审核中...)

前往app查看评论内容

#NICE#

2016 NICE指南：婴幼儿，儿童和年轻人临终关怀（NG.61）

2016-12-11

fusion (审核中...)

前往app查看评论内容

#NICE#

2015 NICE指南：慢性肾病患者贫血的管理（NG8）

2016-12-11

fusion (审核中...)

前往app查看评论内容

#NICE#

2015 NICE技术评估指南：阿哌沙班用于深静脉血栓形成和/或肺栓塞的治疗和二级预防（TA341）

2016-12-10

fusion (审核中...)

前往app查看评论内容

#NICE#

2015 NICE指南：降低成人住院患者静脉血栓栓塞风险（CG92）

2016-12-10

fusion (审核中...)

前往app查看评论内容

#NICE#

2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）

2016-12-09

科室
- - 订阅+
  - 更多科室
工具
服务